Ron Frieson - 17 Jan 2025 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for Ronald E. Frieson
Issuer symbol
AKBA
Transactions as of
17 Jan 2025
Net transactions value
+$9,045
Form type
4
Filing time
22 Jan 2025, 16:06:17 UTC
Previous filing
10 Jun 2024
Next filing
11 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Options Exercise $9,045 +20,100 +27% $0.4500 93,800 17 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKBA Stock Option (Right to buy) Options Exercise $0 -20,100 -100% $0.000000 0 17 Jan 2025 Common Stock 20,100 $0.4500 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.